CNBC - COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Novo Nordisk AS said its insulin drug Levemir has been approved for treatment of diabetes type 1 and 2 in Japan. The group said it plans to launch Levemir on the Japanese market before ...